Fucoxanthin Alleviates Lipopolysaccharide-Induced Inflammation and Immunosuppression in RAW264.7 Macrophages
Authors:
- 1 April 2023
- journal article
- research article
- Published by Pleiades Publishing Ltd in Doklady Biochemistry and Biophysics
- Vol. 509 (1) , 81-85
Abstract
Fucoxanthin (FX) has been reported to reduce mortality in mouse models of sepsis, but its exact cause remains to be determined. In the present study, we evaluated the immunomodulatory properties of FX in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. Our results showed that FX could not only suppress the immune activation responses caused by LPS primary stimulation, but also antagonize LPS restimulation-induced immunosuppression in macrophages. The immunomodulatory capabilities of FX was mainly demonstrated by regulating the production of the inflammatory mediator under different LPS stimuli. Furthermore, we found that adenosine monophosphate-activated protein kinase (AMPK) activation was required for FX’s anti-inflammatory and anti-immunosuppressive activities. Our results complement existing data supporting the clinical potential for FX in treating sepsis.Keywords
This publication has 10 references indexed in Scilit:
- Biomarkers for sepsis: more than just fever and leukocytosis—a narrative reviewCritical Care, 2022
- Nicotinamide pathways as the root cause of sepsis – an evolutionary perspective on macrophage energetic shiftsThe FEBS Journal, 2021
- Fucoxanthin alleviates palmitate-induced inflammation in RAW 264.7 cells through improving lipid metabolism and attenuating mitochondrial dysfunctionFood & Function, 2020
- Population-Specific Metabolic Alterations in Professional Antigen-Presenting Cells Contribute to Sepsis-Associated ImmunosuppressionShock, 2020
- Fucoxanthin, a Marine Xanthophyll Isolated From Conticribra weissflogii ND-8: Preventive Anti-Inflammatory Effect in a Mouse Model of SepsisFrontiers in Pharmacology, 2019
- Temporal Trends in Incidence, Sepsis-Related Mortality, and Hospital-Based Acute Care After SepsisCritical Care Medicine, 2018
- Towards precision medicine for sepsis patientsCritical Care, 2017
- The new normal: immunomodulatory agents against sepsis immune suppressionTrends in Molecular Medicine, 2014
- Therapeutic (Dis)illusion During SepsisCritical Care Medicine, 2013
- Fucoxanthin, a Marine Carotenoid Present in Brown Seaweeds and Diatoms: Metabolism and Bioactivities Relevant to Human HealthMarine Drugs, 2011